| Catalog Number |
08P49-20 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
06/26/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
|
| |
|
Event or Problem Description
|
|
The customer reported a falsely elevated alinity i ca125 result on one patient.Results provided: (b)(6) 2019 = 136 u/ml; new sample tested at another laboratory (method unknown) = 16; new sample from other laboratory processed on this alinity = 16 u/ml.It is unknown if the patient is diagnosed with ovarian cancer.No impact to patient management was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
A review of complaints for the alinity i ca 125 ii (list 8p49), lot# 93256fp00 assay determined that there are no trends for the product related to patient results.Return testing was not completed as returns were not available.A review of the manufacturing documentation did not identify any issues associated with the customers observation.Accuracy testing was performed on lot# 93256fp00 with an internal ca 125 panel and all criteria was met indicating acceptable product performance.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the alinity i ca125 ii (list 8p49), lot# 93256fp00 assay.
|
| |
|
Search Alerts/Recalls
|